Physician profile
Michael Patrick Mott
NPI 1477593937
$11,738.78
in general payments reported to CMS, 2019-2025
12 companies · $1,897 in 2025
The $1,897 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,737 · 2020: $117 · 2021: $2,010 · 2022: $904 · 2023: $3,060 · 2024: $15.10 · 2025: $1,897.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $3,500 · Food and Beverage: $994 · Travel and Lodging: $478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $3,500.00 |
| Food and Beverage | $993.69 |
| Travel and Lodging | $477.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $6,221.23 | 2019-2023 | |
| Innovation Technologies INC | $1,555.30 | 2019-2023 | Irrisept |
| Deciphera Pharmaceuticals INC. | $1,503.40 | 2025 | Vimseltinib |
| Onkos Surgical, INC. | $1,002.96 | 2019-2024 | Eleos Limb Salvage System |
| Zimmer Biomet Holdings, INC. | $529.77 | 2019-2023 | |
| Aadi Bioscience, INC. | $247.42 | 2025 | Fyarro |
| Bone Support INC. | $230.71 | 2021 | |
| Depuy Synthes Sales INC. | $145.75 | 2025 | Attune, Inhance |
| Djo, LLC | $131.40 | 2023 | Donjoy, Aircast |
| Carbofix Orthopedics INC | $120.20 | 2023 | |
| Stryker Corporation | $38.81 | 2023 | Pro-Dense |
| Smith+Nephew, INC. | $11.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.